Accelerate to discover
Related topics
Cytek full Spectrum flow Cytometry webinar: Part II – panel design and troubleshooting
Jan 11, 2021
In this session, we will continue to look at full spectrum flow cytometry and look at considerations for fluorescence...
CQ1 webinar : optimizing high-content imaging of 3D models for drug discovery
Jan 7, 2021
In vitro spheroid models are fast becoming the de facto standard for drug discovery applications, largely due to their...
IncuCyte for in-vitro analysis of SARS-CoV-2 vaccine candidate
Jan 4, 2021
Watch this video to learn how researcher at Humane Genomics are utilizing the Incucyte platform for the in-vitro...
Bruker webinar: Ear evolution in fossil mammals
Nov 27, 2020
Hearing is just one of the functions aside of providing balance. Even juveniles obtain a fully developed ear region...
Curiox webinar - how to retain more cells for Single Cell Sequencing and proteogenomics ?
Oct 28, 2020
Do you think that centrifuging cells at 500 x g is not going to cause issues? Moreover, sample prep involving...
Developing tools for multiplex to single EV analysis pipelines
Sep 30, 2020
Extracellular vesicles (EVs) are lipid spheres released from cells. EVs express proteins and contain cargo that pertain...
IncuCyte webinar : clonal heterogeneity promotes metabolite exchange to support pancreatic tumor
Sep 25, 2020
Pancreatic ductaladenocarcinoma (PDA) is the third leading cause of cancer related death in the United States,...
Are you still using traditional methodologies for your Oncology cell metabolism studies?
Sep 10, 2020
In this infographic, learn about the challenges experienced by scientists in analysing cellular metabolism and how...
Nov 22, 2018
Researchers developed an assay to measure CLL cell interactions with endothelium under shear force using a Bioflux 200 and blocked CD62L using the anti-CD62L antibody DREG-56. CLL cell interactions with endothelium were visualized by time-lapse microscopy and CLL cell movement was tracked and quantified. Data will be discussed in the webinar and will establish targeting CD62L inhibits CLL cell/endothelial cell interactions and is accentuated by co-administration with ibrutinib. These data imply that some of the clinical effects caused by ibrutinib are due to a reduced capacity of CLL cells to engage endothelium and extravasate.
Dr. Chris Pepper, Professor in Cancer Studies, University of Sussex, UK
Related technologies: Cell interaction studies
Get more info
Brand profile
With BioFlux System for live cell analysis under shear flow and IsoFlux System for circulating tumor cell analysis, Fluxion Biosciences turn power of benchtop cellular analysis with advanced tools to automate complex assays.
More info at:
www.fluxionbio.com
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
